← Back to Search

Communication and Intimacy Therapy for Prostate Cancer

N/A
Waitlist Available
Led By David W. Kissane, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient has a primary diagnosis of localized (early stage) prostate cancer
ECOG performance status 0 or 1 at the time of initial recruitment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.

Who is the study for?
This trial is for men with early stage prostate cancer who've had surgery within the past year, and their partners. They must live close to the recruitment center, have been together for at least a year, and be able to hear well enough to participate in therapy sessions.Check my eligibility
What is being tested?
The study is testing whether a special therapy program can help improve communication and intimacy between men with early stage prostate cancer and their partners. Participants are randomly placed into groups to either receive this therapy or not.See study design
What are the potential side effects?
Since this trial involves a therapy program rather than medication, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses as they work through communication and intimacy issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My prostate cancer is in the early stage and has not spread.
Select...
I am fully active or restricted in physically strenuous activity but can do light work.
Select...
I had surgery within the last year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Descriptive characteristics of study measures
Feasibility and acceptability
Impact of communication intervention on couples' psychological adaptation, relationship closeness, and sexual intimacy

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,520 Total Patients Enrolled
132 Trials studying Prostate Cancer
51,974 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,053 Total Patients Enrolled
560 Trials studying Prostate Cancer
507,073 Patients Enrolled for Prostate Cancer
David W. Kissane, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Media Library

Communication and Intimacy-Enhancing Therapy Clinical Trial Eligibility Overview. Trial Name: NCT00503646 — N/A
Prostate Cancer Research Study Groups:
Prostate Cancer Clinical Trial 2023: Communication and Intimacy-Enhancing Therapy Highlights & Side Effects. Trial Name: NCT00503646 — N/A
Communication and Intimacy-Enhancing Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT00503646 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing recruitment process for this clinical research?

"This medical research is not currently seeking any further participants. It was initially posted in the month of May 2007, and last modified on September 16th 2013. Nevertheless, other clinical trials are actively recruiting patients right now with a total of 1570 studies available."

Answered by AI
~6 spots leftby Apr 2025